BengiBio is a genomic intelligence company. We build software that translates whole-genome sequencing data into actionable clinical outputs — from antimicrobial resistance prediction to genomic biomarker discovery and assay validation. Both platforms are designed to meet FDA regulatory requirements from Day 1.
Who we are
BengiBio develops software platforms that apply machine learning and computational genomic analysis to solve clinical problems that require FDA-grade reliability — problems where an incorrect answer has direct patient or regulatory consequences.
We are not a sequencing company. We are not a laboratory. We are a software company that makes genomic data clinically useful.
Both platforms are currently seeking pilot partners — pharmaceutical sponsors, IVD developers, and clinical researchers — to validate and deploy our software in real clinical workflows.
Regulatory requirements built in from Day 1 — not retrofitted for compliance after the fact.
Proprietary ML pipelines on WGS, metagenomic, and host genomic data — interpretable and traceable.
Uncertainty quantification and full documentation to FDA IVD and bioanalytical validation standards.
Founding team
GMP-validated AI/ML software, built from scratch in regulated pharmaceutical environments — experience the founding team brings directly to BengiBio.
Our platforms
Each platform is purpose-built for its domain — with its own computational engine, regulatory pathway, and customer base.
Connect with BengiBio
Whether you are a clinician, hospital administrator, diagnostics company, drug developer, or researcher — we want to hear from you.
BengiBio, Inc. · Intelligent Genome Solutions · © 2026 All rights reserved